RRC ID 65935
著者 Tseng JH, Bisogna M, Hoang LN, Olvera N, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Levine DA, Jelinic P.
タイトル miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
ジャーナル Sci Rep
Abstract Uterine carcinosarcomas (UCSs) are highly aggressive malignancies associated with poor prognoses and limited treatment options. These tumors are hypothesized to develop from the endometrial adenocarcinoma (EAC) through epithelial-mesenchymal transition (EMT). We test this long-standing hypothesis by depleting miR-200, a family of microRNAs critical for EMT, in EAC cell lines. Our data suggest that UCSs do not develop from EACs via EMT. Clinically more relevant, we show that miR-200 expression in UCS cells induces a robust mesenchymal-epithelial transition (MET). Using in vitro and murine xenograft models, we demonstrate decreased growth and aggressiveness of miR-200-overexpressing UCS cell lines. Whole transcriptome analysis confirmed changes consistent with an MET and also revealed changes in angiogenic genes expression. Finally, by treatment of UCS-xenografted mice with miR-200c incorporated in DOPC nanoliposomes, we demonstrate anti-tumor activities. These findings suggest that ectopic miR-200 expression using advanced microRNA therapeutics may be a potential treatment approach for patients with UCS.
巻・号 7(1)
ページ 3614
公開日 2017-6-15
DOI 10.1038/s41598-017-03972-7
PII 10.1038/s41598-017-03972-7
PMID 28620240
PMC PMC5472620
MeSH Animals Carcinosarcoma / genetics* Carcinosarcoma / pathology* Cell Adhesion Cell Movement Cell Proliferation Cell Survival Computational Biology / methods Disease Models, Animal Epithelial-Mesenchymal Transition / genetics* Female Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Mice MicroRNAs / genetics* Mutation Neovascularization, Pathologic / genetics Uterine Neoplasms / genetics* Uterine Neoplasms / pathology* Xenograft Model Antitumor Assays
IF 3.998
リソース情報
ヒト・動物細胞 JHUCS-1(RCB1547)